Rate Rumble, Ozempic’s Price Plunge, & Retail Rift: What It Means for Your Money

In this episode of Upticks, Jake Falcon and Corey Bittner discuss recent financial news and its implications for investors. They analyze the Federal Reserve's decision to hold rates steady while hinting at future cuts, the S&P's AA+ rating for the U.S. with warnings about deficits, and Novo Nordisk's price reduction for Ozempic. They also discuss Target's retail shakeup, including the departure of Ulta from its stores, and a partnership between CME Group and FanDuel to develop an events contracts platform, which sparks a debate about the gamification of financial markets. Finally, they touch on the AI arms race between Google and Apple, emphasizing the importance of embracing new technology for productivity.